Kewalramani Reshma

Average Profitability
20.8%
Insider Buys Quantity
1
Insider Buys Sum
$1.96M
Insider Sells Quantity
27
Insider Sells Sum
$60.92M

Insider Activity of Kewalramani Reshma

According to the SEC Form 4 filings, Kewalramani Reshma, being in a position of

  1. CEO & President at Vertex Pharmaceuticals Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 84602 shares for $39.57M,
    over all time since 2018-10-08, has bought 10000 shares for $1.96M, and sold 158350 shares for $60.92M.

The largest purchase of all time was on 2021-08-19 and amounted to 10000 shares of Vertex Pharmaceuticals Incorporated for $1.96M.

The largest sale of all time was on 2024-11-08 and amounted to 15198 shares of Vertex Pharmaceuticals Incorporated for $7.83M.

Biography of Kewalramani Reshma

Dr. Reshma Kewalramani, aged 49, has made an indelible mark as a leading figure in the biotechnology and pharmaceutical industry, currently serving as the Chief Executive Officer and President of Vertex Pharmaceuticals Incorporated. She joined Vertex in 2017 as the Senior Vice President of Global Medicines Development and Medical Affairs and was instrumental in the clinical development and regulatory approval of several groundbreaking therapies for cystic fibrosis. Kewalramani's educational background is as impressive as her professional …

2024-11-08SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
15,198
0.0059%
$515.00$7.83M-7.53%
2024-07-30SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
15,202
0.0059%
$505.00$7.68M+0.15%
2024-07-22SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
15,202
0.0059%
$497.00$7.56M-3.61%
2024-05-24SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
1,565
0.0006%
$457.00$715,205+4.48%
2024-05-20SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
15,202
0.0059%
$447.00$6.8M+6.77%
2023-12-15SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
17,135
0.0066%
$407.00$6.97M+7.13%
2023-12-13SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
5,098
0.0019%
$397.00$2.02M+8.44%
2023-11-13SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
5,097
0.002%
$377.00$1.92M+13.84%
2023-07-17SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
7,828
0.003%
$355.00$2.78M+12.04%
2023-04-27SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
3,317
0.0013%
$339.08$1.12M+5.5%
2023-01-25SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
10,000
0.0039%
$315.05$3.15M+10.31%
2022-08-15SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
11,689
0.0046%
$305.06$3.57M+2.06%
2022-06-24SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
11,689
0.0045%
$291.30$3.41M+2.7%
2021-08-19PurchaseVertex Pharmaceuticals Incorporated
VRTX
CEO & President
10,000
0.0039%
$195.65$1.96M+20.8%
2020-08-06SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
2,073
0.0008%
$271.20$562,205-20.83%
2020-05-15SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
99
<0.0001%
$284.17$28,132-19.72%
2020-05-06SaleVertex Pharmaceuticals Incorporated
VRTX
CEO & President
2,074
0.0008%
$272.85$565,882-13.36%
2020-02-25SaleVertex Pharmaceuticals Incorporated
VRTX
EVP and CMO
3,634
0.0014%
$233.45$848,371+10.97%
2020-02-18SaleVertex Pharmaceuticals Incorporated
VRTX
EVP and CMO
1,183
0.0005%
$243.51$288,070+3.78%
2020-02-06SaleVertex Pharmaceuticals Incorporated
VRTX
EVP and CMO
2,074
0.0008%
$239.44$496,600+6.75%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.